Blood Collection Tubes Market Analysis | 2026-2034

Market Size & Opportunities

Global Demand Analysis & Sales Opportunities in Aircraft Interiors Market

• The annual demand for blood collection tubes was USD 4.9 billion in 2025 and is expected to reach USD 5.0 billion in 2026, up 3.7% than the value in 2025.

• During the forecast period (2026-2034), the market is expected to grow at a CAGR of 3.4%. The annual demand will reach USD 6.6 billion in 2034, which is almost 1.35 times the demand in 2025.

• North America had a market share of 35.2% in 2025, generating the largest demand across regions.

• Vacuum tubes will continue to dominate in the coming years.

• Among the product types, serum separation tubes are estimated to generate the highest demand, capturing the largest market share throughout the forecast period.

• By material type, plastic material is expected to continue its dominance and also anticipated to grow at the fastest rate in the market.

• By end-use industry type, healthcare centers are anticipated to remain dominant as well as the fastest-growing end-use industry over the years.

“According to the Senior Analyst at Stratview Research, the blood collection tubes market will generate a cumulative sales opportunity worth USD 50+ billion during 2026-2034. During the forecasting period, Vacuum Tubes, Healthcare centers, & Asia-Pacific are some of the growth opportunity segments to bank upon.”

Sharpen Your Strategies to Explore this USD 50+ billion Opportunity. Get Free Sample of Our Report: “Here”.

Market Statistics

Have a look at the sales opportunities presented by the blood collection tubes market in terms of growth and market forecast.

Want to Explore the Market Opportunities? Get Free Sample “Here”.

Market Dynamics

The blood collection tubes market is evolving with trends like automation and standardization for efficiency, rising demand for specialized tubes catering to specific diagnostics, and an increased focus on environmental sustainability through eco-friendly materials and practices.

Factors driving the growth of the blood collection tubes market include the increasing prevalence of chronic diseases, rising demand for diagnostic testing, advancements in healthcare infrastructure, and the expanding aging population.

Market Drivers:

Increasing Prevalence of Chronic Diseases

The growing burden of chronic diseases is driving market growth in blood collection tubes because the diagnosis, monitoring, and follow-up of conditions such as diabetes, cardiovascular disease, and cancer depend on recurring laboratory blood tests. The increasing number of patients requiring screening and disease monitoring translates into a larger volume of blood specimens collected across hospitals, diagnostic laboratories, and outpatient settings, supporting sustained demand for different tube types.

• The 2025 IDF Diabetes Atlas estimates that 589 million adults aged 20–79 years are living with diabetes worldwide, equivalent to 1 in 9 adults. The number is projected to reach 853 million by 2050, while 43% of adults with diabetes, or approximately 252 million people, remain undiagnosed, highlighting the continuing need for diagnostic and monitoring procedures that require blood specimens.

• The International Agency for Research on Cancer (IARC) estimated 20.6 million new cancer cases globally in 2024, with 9.8 million deaths. The large and growing patient population supports continued demand for blood-based laboratory testing used in cancer diagnosis, treatment assessment, and disease monitoring.

Rising Demand for Diagnostic Testing

The expanding use of diagnostic testing across preventive care, disease detection, and treatment monitoring is strengthening market demand for blood collection tubes, as many routine laboratory investigations require properly collected and preserved blood specimens. Greater healthcare utilization and the growing emphasis on early diagnosis are increasing the volume of laboratory testing, creating recurring consumption of blood collection tubes across hospitals, diagnostic laboratories, and outpatient facilities.

Rising Demand for Diagnostic Testing

The expanding use of diagnostic testing for disease detection, preventive screening, treatment decisions, and patient monitoring is supporting market demand for blood collection tubes. As healthcare systems increase access to laboratory services and more patients undergo diagnostic investigations, the volume of blood specimens requiring collection and processing also rises, creating recurring demand for tubes across hospitals, diagnostic laboratories, and outpatient facilities.

• According to the National Statistical Office (NSO) 80th Round Household Social Consumption: Health survey, conducted during 2025, 13.1% of India’s population reported suffering from an ailment during the 15 days preceding the survey, compared with 7.5% in 2017–18. The survey also reported an increase in non-communicable diseases such as hypertension, diabetes, and thyroid disorders, strengthening the need for diagnostic and monitoring services that frequently rely on blood specimens.

• According to the Australian Institute of Health and Welfare (AIHW) report “Pathology, imaging and other diagnostic services,” the number of pathology tests in Australia increased from 89.8 million in 2014–15 to 123.8 million in 2024–25. The number of pathology tests per 100 people also increased from 382 to 455 during the period, demonstrating the continued expansion of laboratory testing and the associated need for blood specimen collection consumables.

“As per an analyst at Stratview Research, the blood collection tubes market is evolving in response to changing diagnostic requirements. While conducting the market analysis and speaking with leading industry players, it is evident that the next decade will be shaped by rising demand for specialized tubes designed for specific diagnostic applications, alongside a growing focus on environmentally sustainable materials and practices.”

Align with the Mega Trends Shaping the Industry. Get Free Sample “Here”

Market Challenges

Stringent Regulatory and Quality Compliance Requirements

Manufacturers of blood collection tubes must comply with multiple regulatory and quality standards, including FDA requirements, EU MDR, ISO 6710, and CLSI guidelines. Products must undergo rigorous validation for parameters such as sterility, additive accuracy, tube integrity, and biocompatibility before entering the market. These requirements increase development and compliance costs and can extend product approval timelines, creating a challenge for market growth as manufacturers seek to introduce new products while maintaining regulatory conformity.

Intense Price Competition

The blood collection tubes market faces intense competition from multinational manufacturers as well as regional suppliers, particularly as many tube designs and applications are standardized. Large hospitals, diagnostic laboratories, and healthcare networks often use competitive procurement and tendering processes, placing pressure on suppliers to offer cost-effective products without compromising quality or regulatory compliance. This pricing pressure can constrain manufacturers' margins and make it more difficult to sustain market share while investing in product development and manufacturing capabilities.

Market Opportunities

Growing Adoption of Specialized Tubes for Advanced Diagnostics

The expansion of molecular diagnostics, liquid biopsy, proteomics, and other specialized testing is creating opportunities for manufacturers to develop blood collection tubes with enhanced sample stabilization and preservation capabilities. Unlike conventional tubes designed primarily for routine testing, these specialized products can address the requirements of emerging diagnostic workflows, creating opportunities for product differentiation and higher-value applications within the blood collection tubes market.

• In July 2025, OraSure Technologies launched its HEMAcollect™ PROTEIN evacuated blood collection tube for proteomic research, designed to preserve and stabilize plasma proteins in whole blood for up to 7 days at ambient temperature. The development demonstrates an opportunity for specialized tubes that extend sample stability and simplify transportation for advanced diagnostic and research applications.

• Nasmed Diagnostics expanded its blood collection tube portfolio in 2025 to include tubes for cell-free DNA alongside conventional EDTA, heparin, citrate, and clot-activator tubes. The company's portfolio reflects growing opportunities for application-specific collection tubes designed around specialized diagnostic requirements rather than standardized blood collection alone.

Segments' Analysis

By Product Type

“Serum separation tubes are expected to remain dominant, while plasma separation tubes and rapid serum tubes are expected to register the fastest growth during the forecast period.”

Based on product type, the blood collection tubes market is segmented into serum separation tubes, EDTA tubes, plasma separation tubes, rapid serum tubes, and others.

Serum separation tubes are expected to maintain their dominant position throughout the forecast period, supported by their extensive use in routine clinical chemistry, immunology, serology, and other diagnostic investigations requiring serum samples. These tubes combine clot activators with separator gels to enable efficient serum separation, simplifying specimen processing and supporting their widespread use across hospitals, diagnostic laboratories, and other healthcare facilities. The broad range of routine tests performed using serum specimens continues to support their widespread adoption.

Meanwhile, plasma separation tubes and rapid serum tubes are projected to register the fastest growth during the forecast period. Their growth is supported by the increasing need for faster sample processing, improved specimen quality, and more efficient laboratory workflows. Plasma-based testing is widely used across clinical diagnostics, while rapid serum tubes can accelerate clot formation and reduce processing time, making them increasingly relevant as healthcare providers place greater emphasis on faster diagnostic turnaround.

By Material Type

“Plastic blood collection tubes are expected to remain dominant and the fastest-growing material type during the forecast period.”

Based on material type, the blood collection tubes market is segmented into plastic blood collection tubes and glass blood collection tubes.

Plastic blood collection tubes are expected to maintain their dominant position and register the fastest growth throughout the forecast period. Their widespread adoption is supported by their lightweight construction, lower breakage risk, and greater convenience during transportation and handling. Plastic tubes are also well suited to automated laboratory workflows and high-volume specimen processing, making them increasingly preferable across hospitals and diagnostic laboratories. Their combination of durability, handling convenience, and compatibility with modern laboratory practices supports their continued adoption.

Glass blood collection tubes remain suitable for applications where rigidity, chemical resistance, and specific specimen-handling properties are required. However, their susceptibility to breakage and greater handling requirements limit their use in some high-volume healthcare environments compared with plastic alternatives.

By End-User Type

“Healthcare centers are expected to remain the largest end-user segment during the forecast period, while research centers are expected to witness significant growth.”

Based on end-user type, the blood collection tubes market is segmented into healthcare centers, diagnostic centers, and research centers.

Healthcare centers are expected to maintain their dominant position throughout the forecast period, supported by the high volume of patients undergoing routine examinations, disease diagnosis, treatment monitoring, and follow-up testing. Hospitals and other healthcare facilities perform a broad range of blood-based investigations across different departments, generating recurring requirements for multiple types of blood collection tubes. The increasing emphasis on early diagnosis and efficient patient management further strengthens the role of healthcare centers as the largest end-user group.

Meanwhile, research centers are expected to witness significant growth, supported by increasing research activity in areas such as drug discovery, biomarker identification, disease mechanisms, and personalized medicine. These applications require the collection, preservation, and analysis of high-quality blood specimens, creating greater requirements for specialized collection products suited to research workflows.

By Tube Type

“Vacuum blood collection tubes are expected to remain dominant and register faster growth during the forecast period, supported by standardized and efficient blood collection.”

Based on tube type, the blood collection tubes market is segmented into vacuum blood collection tubes and non-vacuum blood collection tubes.

Vacuum blood collection tubes are expected to remain the dominant and faster-growing segment during the forecast period. Their adoption is supported by their ability to draw a predetermined volume of blood directly into a sealed tube, providing greater consistency in specimen collection and reducing the potential for contamination. The standardized vacuum mechanism also enables efficient collection of multiple specimens during a single patient visit, making these tubes particularly suitable for hospitals and diagnostic laboratories handling high testing volumes.

Non-vacuum blood collection tubes continue to be used in specific applications where blood is transferred into the tube manually or where vacuum-based collection is less suitable. However, their greater dependence on manual handling and comparatively lower level of standardization limits their adoption relative to vacuum tubes.

Regional Analysis

“North America is expected to remain dominant, while the Rest of the World is projected to register the fastest growth during the forecast period.”

In terms of regions, North America is expected to lead the market during the forecast period, driven by robust economic growth, advanced healthcare infrastructure, and a high adoption rate of cutting-edge technologies. It boasts a well-established and advanced healthcare infrastructure, providing a conducive environment for adopting innovative medical technologies.

The Rest of the World is expected to register the fastest growth during the forecast period. This acceleration is driven by rapid expansion of healthcare infrastructure, broader access to diagnostic services, rising healthcare spending, and increasing prioritization of early detection and preventive care across emerging markets.

Asia‑Pacific is also forecast to grow quickly, propelled by a large and aging population with expanding healthcare needs, a rising burden of chronic and infectious diseases that increase demand for testing, and significant investment in healthcare capacity and technology.

Europe will continue to see robust demand due to its comprehensive healthcare systems, an aging population with a growing prevalence of chronic conditions, rising interest in minimally invasive diagnostics, and ongoing technological advancements in blood collection and diagnostic devices.

“The study indicates that over 75% of the blood collection tubes market is concentrated within the top 10 countries. A few countries are the demand powerhouses and will drive the regional markets in big ways offering business opportunities.”

Speak to Us for Deep-Diving into a Country/Region-Specific Opportunity. Contact Us “Here”.

Competitive Landscape

The market is concentrated, with around 40 global and regional players. Leading players compete in some of the governing factors, including price, service offerings, regional presence, etc.

The following are the key players in the blood collection tubes market:

• Becton, Dickinson and Company

• Greiner AG

• Qiagen NV

• Cardinal Health

• Sarstedt Ag & Co. Ag

• McKesson Medical-Surgical

• SEKISUI CHEMICAL Group

• Zhejiang Gongdong Medical Technology Co., Ltd.

• Guangzhou Improve Med Instrument

• Nipro Corporation

Note: The above list is not an exhaustive list of the key players in the market. If your company is active in this market and would like to be considered for inclusion in future editions of this study, please contact us at [email protected].  

Have the Competitive Edge with Our Intelligence. Get Free Sample “Here”.

Recent Developments / Mergers & Acquisitions

Recent mergers & acquisitions and other developments in the aircraft interiors market reflect evolving market trends and impact the market. Below are a few recent developments in the market –

• In May 2026, Drummond Scientific Company acquired Accu-Glass, LLC, a manufacturer of high-precision glass capillaries used in medical and diagnostic applications. The acquisition expands Drummond’s capabilities in medical technology, diagnostics, and sample-collection products, strengthening its position across laboratory and specimen-collection applications. 

• In February 2026, Q-Sera Pty Ltd has in collaboration with Terumo Group launched its VenoJect II RAPClotTM blood collection tubes in the Japanese market. The tube is intended to rapidly produce high quality serum using Q-Sera’s ecarin (RAPClot) technology. Terumo Corporation has the exclusive right to manufacture VenoJect II RAPClotTM blood collection tubes for the Japanese market.

• In February 2026, Waters completed the integration of BD’s Biosciences & Diagnostic Solutions business following its acquisition from Becton, Dickinson and Company in a transaction valued at approximately USD 17.5 billion. Announced in July 2025, the deal expanded Waters’ presence in laboratory diagnostics by adding BD’s diagnostic solutions portfolio to its business.

• In October 2025, GSI Group acquired GenesisBPS, a manufacturer of specialized blood-processing equipment and laboratory consumables. The acquisition expanded GSI Group’s portfolio of single-use laboratory products serving diagnostic laboratories, hospitals, research institutions, and other life-science customers. 

• In October 2025, Ahlstrom acquired EBF, a U.S.-based manufacturer of natural-fiber medical devices used for the collection and preservation of biological samples, including newborn-screening cards. The acquisition strengthened Ahlstrom’s life-science portfolio and expanded its capabilities in materials used for blood and urine testing.

Report Scope

Market Definition

Blood collection tubes are typically made of plastic or glass and are available in various sizes and configurations, each designed for specific types of blood tests and analysis. The tubes may contain additives or coatings to preserve the integrity of the blood sample and prevent clotting or contamination. These tubes play a crucial role in the healthcare industry, enabling healthcare professionals to collect, transport, and store blood specimens efficiently and securely.

The market encompasses a wide range of products, including vacuum tubes, safety-engineered tubes, and specialized tubes for specific applications, such as serum separation or molecular diagnostics.

Report Structure

This report provides the most comprehensive market intelligence. The report structure has been kept so that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players and those looking to enter the market.

The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.

• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.

• Market trend and forecast analysis.

• Market segment trend and forecast.

• Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.

• Attractive market segments and associated growth opportunities.

• Emerging trends.

• Strategic growth opportunities for the existing and new players.

• Key success factors.

Want a Report Tailor-Made to Your Objectives? Speak with Our Analyst at [email protected]

Segmentation

The report provides detailed insights into market dynamics to enable informed business decision-making and the formulation of growth strategies based on market opportunities.

The blood collection tubes market is segmented into the following categories:

Blood Collection Tubes, By Product Type

• Serum Separation Tubes

• EDTA Tubes

• Plasma Separation Tubes

• Rapid Serum Tubes

• Others

Blood Collection Tubes, By Material Type

• Plastic Blood Collection Tubes

• Glass Blood Collection Tubes

Blood Collection Tubes, By End-User Type

• Healthcare Centers Blood Collection Tubes

• Diagnostic Centers Blood Collection Tubes

• Research Centers Blood Collection Tubes

Blood Collection Tubes, By Tubes Type

• Vacuum Blood Collection Tubes

• Non-Vacuum Blood Collection Tubes

Blood Collection Tubes, By Region

• North America (Country Analysis: The USA, Canada, and Mexico)

• Europe (Country Analysis: Germany, France, Spain, The UK, and the Rest of Europe)

• Asia-Pacific (Country Analysis: Japan, China, India, and Rest of Asia-Pacific)

• Rest of the World (Country Analysis: Brazil, Saudi Arabia, and Others)

 Looking for a Deep Dive? Speak with Our Analyst at [email protected]

Research Methodology

This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s blood collection tubes market realities and future market possibilities for the forecast period.

The report segments and analyzes the market in the most detailed manner to provide a panoramic view. The vital data/information provided in the report can play a crucial role for market participants and investors in identifying low-hanging fruit in the market and formulating growth strategies to expedite their growth.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with market players across the value chain in all four regions, as well as with industry experts, to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respected clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected]